PHARMACOKINETIC CONSIDERATIONS ON RESISTANCE TO ANTICANCER DRUGS

被引：0
|
作者：
DEDRICK, RL
ZAHARKO, DS
BENDER, RA
BLEYER, WA
LUTZ, RJ
机构：
[1] NIH, DIV RES SERV,BIOMED ENGN & INSTRUMENTATION BRANCH, BLDG 13,ROOM 3W13, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT, PHARMACOKINETICS & PHARMACODYN SECT, LAB CHEM PHARMACOL, BETHESDA, MD USA
[3] UNIV WASHINGTON, CHILDRENS ORTHOPEDIC HOSP, DEPT PEDIAT, DIV HEMATOL ONCOL, SEATTLE, WA USA
[4] NCI, DIV CANC TREATMENT, MED BRANCH, BETHESDA, MD USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1975年 / 59卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：795 / 804
页数：10
相关论文
共 50 条
  • [11] Pharmacokinetic drug interactions of oral anticancer drugs
    Satory, Julia Gampenrieder
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (04) : 298 - 302
  • [12] MECHANISMS OF RESISTANCE TO ANTICANCER DRUGS
    JARDILLIER, JC
    ANNALES DE BIOLOGIE CLINIQUE, 1993, 51 (3-5) : 270 - 271
  • [13] Pharmacokinetic considerations for drugs administered in the critically ill
    Tansley, Gavin
    Hall, Richard
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (02) : 89 - +
  • [14] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge J.J.
    Ahn C.-H.
    Andrews P.A.
    Brower M.E.
    Giorgio D.W.
    Goheer M.A.
    Lee-Ham D.Y.
    McGuinn W.D.
    Schmidt W.
    Sun C.J.
    Tripathi S.C.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (3) : 173 - 185
  • [15] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge, JJ
    Ahn, CH
    Andrews, PA
    Brower, ME
    Giorgio, DW
    Goheer, MA
    Lee-Ham, DY
    McGuinn, WD
    Schmidt, W
    Sun, CJ
    Tripathi, SC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (03) : 173 - 185
  • [16] Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs
    Romano Danesi
    Stefano Fogli
    Alessandra Gennari
    Pierfranco Conte
    Mario Del Tacca
    Clinical Pharmacokinetics, 2002, 41 : 431 - 444
  • [17] Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
    Bauer, Martin
    Zeitlinger, Markus
    Langer, Oliver
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 306 - 306
  • [18] Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs
    Danesi, R
    Fogli, S
    Gennari, A
    Conte, P
    Del Tacca, M
    CLINICAL PHARMACOKINETICS, 2002, 41 (06) : 431 - 444
  • [19] IMPROVING THE USE OF ANTICANCER DRUGS - CLINICAL PHARMACOKINETIC APPROACHES
    COLLINS, JM
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1988, 24 (9-10): : 483 - 487
  • [20] Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs
    Takara, K
    Tanigawara, Y
    Komada, F
    Nishiguchi, K
    Sakaeda, T
    Okumura, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (12) : 1355 - 1359
12345